Effects of monamine oxidase inhibitors on qualitive alterations ( Transformation ) of the catalytic properties of amine oxidases.
D006631:Amine Oxidase (Copper-Containing); D000818:Animals; D002384:Catalysis; D002417:Cattle; D003300:Copper; D003641:Deamination; D007490:Iproniazid; D008930:Mitochondria, Liver / Q000201:enzymology; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors; D009829:Oleic Acids; D010084:Oxidation-Reduction; D010293:Pargyline; D051381:Rats; D013440:Sulfides; D013552:Swine; D014191:Tranylcypromine; D014363:Tryptamines; D014439:Tyramine
D008996:Monoamine Oxidase Inhibitors; D009829:Oleic Acids; D013440:Sulfides; D014363:Tryptamines; D014191:Tranylcypromine; D003300:Copper; D010293:Pargyline; D007490:Iproniazid; D006631:Amine Oxidase (Copper-Containing); D008995:Monoamine Oxidase; D014439:Tyramine